Company Filing History:

21 out of 730

Kyowa Hakko Kogyo Co., Ltd.

Years Active: 1979-1997

Loading Chart...

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5607955 - Tricyclic compounds on angiotensin II receptor antagonists (1997-03-04),

2. 5478840 - Tricyclic compounds (1995-12-26),

3. 5478835 - Tricyclic compounds and intermediates thereof (1995-12-26),

4. 5378701 - Tricyclic compounds (1995-01-03),

5. 5340807 - Tricyclic compounds and intermediates thereof (1994-08-23),

6. 5302602 - Tricyclic thromboxane A.sub.2 antagonists (1994-04-12),

7. 5302596 - Tricyclic compounds as TXA.sub.2 antagonists (1994-04-12),

8. 5242931 - Tricyclic compounds as TXA.sub.2 antagonists (1993-09-07),

9. 5239083 - Indole derivatives which inhibit steroid 5.alpha. reductase (1993-08-24),

10. 5143922 - Tricyclic thromboxane A.sub.2 antagonists (1992-09-01),

11. 5118701 - Tricyclic compounds as TXA.sub.2 antagonists (1992-06-02),

12. 5116863 - Dibenz[b,e]oxepin derivative and pharmaceutical compositions thereof (1992-05-26),

13. 5075301 - Furan derivatives useful for the treatment of gastro-intestinal disorders (1991-12-24),

14. 5010104 - Tricyclic compounds (1991-04-23),

15. 5010087 - Tricyclic compounds and TXA.sub.2 antagonistic compositions thereof (1991-04-23),

Title: The Innovative Contributions of Hiroyuki Obase

Introduction: Hiroyuki Obase is a notable inventor based in Mishima, Japan, recognized for his significant contributions to the field of pharmaceutical chemistry. With a remarkable portfolio of 23 patents, he has dedicated his career to developing innovative compounds that address important medical needs.

Latest Patents: Among his latest patents, Obase has introduced tricyclic compounds that function as angiotensin II receptor antagonists. His patented compounds exhibit antagonism to angiotensin II receptors, which are pivotal in managing various cardiovascular diseases. The detailed formula reveals complex chemical structures indicative of advanced pharmaceutical research, showcasing the unique properties of these compounds to potentially enhance therapeutic efficacy.

Career Highlights: Throughout his career, Hiroyuki Obase has worked with prestigious companies, including Kyowa Hakko Kogyo Co., Ltd. His experience in these reputable institutions has allowed him to refine his skills and contribute meaningfully to innovations in the pharmaceutical sector, particularly in the development of new drugs targeting critical health conditions.

Collaborations: Obase's journey is marked by fruitful collaborations with esteemed colleagues, including Kazuhiro Kubo and Etsuo Oshima. Their combined expertise has significantly influenced the successful outcomes of their research initiatives and patent applications, further advancing the field of medicinal chemistry.

Conclusion: Hiroyuki Obase’s innovative spirit and dedication to research have resulted in numerous patents that contribute to the advancement of healthcare solutions. His work serves as an inspiration for future inventors and highlights the importance of collaboration in fostering breakthroughs within the pharmaceutical industry. As the world continues to evolve, the impact of his contributions will likely resonate in the field for years to come.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.